ロード中...
Monoclonal antibody-based therapies for microbial diseases
The monoclonal antibody (mAb) revolution that currently provides many new options for the treatment of neoplastic and inflammatory diseases has largely bypassed the field of infectious diseases. Only one mAb is licensed for use against an infectious disease, although there are many in various stages...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier Ltd.
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2810317/ https://ncbi.nlm.nih.gov/pubmed/20006139 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2009.09.105 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|